Bolt Biotherapeutics (BOLT) Stock Price, Quote, News & History

Comments

Bolt Biotherapeutics Inc (BOLT) Stock Price, Quote, News & History

BOLTNASDAQ

Trade with Public

$4.50

0.214.90%

At close: Mar 24, 5:00 PM EST

$4.76

0.4710.96%

Pre-Market: 4:00 AM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$4.50

Volume / Avg.

0 / 25.70K

Day Range

- - -

52 Wk Range

3.91 - 9.66

Market Cap

$9.15M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

0.05%

Days to Cover

1

Recent Bolt Biotherapeutics Inc News

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today

Avi Kapoor

Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-39.85M

Investing Cash Flow (TTM)

44.30M

Financing Cash Flow (TTM)

19.00K

Free Cash Flow (TTM)

-39.92M

Capital Expenditure (TTM)

-72.00K

Net Change in Cash (TTM)

4.47M

Analyst Trends and Forecast

1

Oct 25

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.10M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.09

PB Ratio (TTM)

0.33

Earnings Yield % (TTM)

-396.67%

Earnings Yield % (FWD)

-219.33%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$13.79

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$11.70M

Debt to Equity

0.87

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$4.50

Volume / Avg.

0 / 25.70K

Day Range

- - -

52 Wk Range

3.91 - 9.66

Market Cap

$9.15M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

0.05%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs in...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Bolt Biotherapeutics (BOLT) stock?

A

You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bolt Biotherapeutics (BOLT) competitors?

A

Other companies in Bolt Biotherapeutics’s space includes: Alzamend Neuro Inc (NASDAQ:ALZN), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Curis Inc (NASDAQ:CRIS), Imunon Inc (NASDAQ:IMNN) and Lunai Bioworks Inc (NASDAQ:LNAI).

Q

What is the forecast, or price target, for Bolt Biotherapeutics (BOLT) stock?

A

Bolt Biotherapeutics has a consensus price target of $17.60.

Q

What is the current price for Bolt Biotherapeutics (BOLT)?

A

The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $4.76 last updated March 20, 2026 at 4:04 PM EDT.

Q

Does Bolt Biotherapeutics (BOLT) pay a dividend?

A

There are no upcoming dividends for Bolt Biotherapeutics.

Q

When is Bolt Biotherapeutics (NASDAQ:BOLT) reporting earnings?

A

Bolt Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Bolt Biotherapeutics (BOLT) going to split?

A

There is no upcoming split for Bolt Biotherapeutics.

Q

What sector and industry does Bolt Biotherapeutics (BOLT) operate in?

A

Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Acurx Pharmaceuticals Inc

AlphaTON Capital Corp

NASDAQ:ATON

$0.33

-1.33%

CollPlant Biotechnologies Ltd

Key Statistics

Open

-

Close

$4.50

Volume / Avg.

0 / 25.70K

Day Range

- - -

52 Wk Range

3.91 - 9.66

Market Cap

$9.15M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

0.05%

Days to Cover

1

Recent Bolt Biotherapeutics Inc News

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today

Avi Kapoor

Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-39.85M

Investing Cash Flow (TTM)

44.30M

Financing Cash Flow (TTM)

19.00K

Free Cash Flow (TTM)

-39.92M

Capital Expenditure (TTM)

-72.00K

Net Change in Cash (TTM)

4.47M

Analyst Trends and Forecast

1

Oct 25

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.10M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.09

PB Ratio (TTM)

0.33

Earnings Yield % (TTM)

-396.67%

Earnings Yield % (FWD)

-219.33%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$13.79

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$11.70M

Debt to Equity

0.87

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$4.50

Volume / Avg.

0 / 25.70K

Day Range

- - -

52 Wk Range

3.91 - 9.66

Market Cap

$9.15M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

56

Short Interest

0.05%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs in...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry